Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05810974
Other study ID # -TBC-
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date April 14, 2023
Est. completion date September 7, 2023

Study information

Verified date April 2023
Source University of Reading
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cardiovascular disease (CVD) is one of the leading causes of mortality worldwide. Inorganic nitrate found in beetroot and green leafy vegetables has been demonstrated to reduce cardiovascular disease risk factors including reducing blood pressure and the stiffness of blood vessels by increasing levels of a compound called nitric oxide. Much of the research to date has focused on the large blood vessels, and little is known about the impact of inorganic nitrate on smaller blood vessels which could be related to cognitive function. The majority of beneficial effects with inorganic nitrate have been observed within young healthy populations. However, it is known that after the menopause women are at an increased risk of cardiovascular disease and have reduced levels of nitric oxide in their body; this could also contribute to the cognitive decline also observed post-menopause. This trial will investigate the impact of inorganic nitrate from beetroot juice on the blood flow in small blood vessels and on cognitive function in postmenopausal women. The hypothesis of the study is that the nitrate in beetroot juice will increase circulating nitric oxide that will then increase blood flow in small blood vessels and improve cognitive function.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 24
Est. completion date September 7, 2023
Est. primary completion date July 7, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 45 Years and older
Eligibility Inclusion Criteria: - Apparently healthy post-menopausal women (age over 45) - Able to understand information sheet and willing to comply with the study protocol and able to give informed consent - Not having menstrual period for 12 months Exclusion Criteria: - Blood pressure <90/60 or > 140/90 mmHg - Medical history of myocardial infarction, angina, thrombosis, stroke, cancer, high cholesterol, liver, renal, respiratory or bowel diseases or diabetes or other endocrine disorder - BMI>30 - Any tobacco and/or nicotine users (or quit within the last 6 months) - Current use of antihypertensive medication - Alcohol intake > 14 units/week - Vigorous exercise > 3 times/ week - Antihypertensive medication users - People who have had hysterectomy - Currently taking hormone replacement therapy or selective oestrogen receptor modulator

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Concentrated beetroot juice
Subjects will consume 70ml shot (Beet-it Sport nitrate 400 shot, James White Drinks) and this drink contains 0.4g inorganic nitrate
Nitrate depleted beetroot juice + potassium nitrate (KNO3)
Nitrate-depleted beetroot juice (70ml) and 0.4g KNO3- will be mixed. (Same appearance and taste with Beet-it sport shot)
Nitrate depleted beetroot juice
Subjects will consume 70ml of (Beet-it Placebo shot, James White Drinks). This drink is the same as the Beet-it Sport nitrate shot but has the nitrate removed.

Locations

Country Name City State
United Kingdom University of Reading Reading UK

Sponsors (1)

Lead Sponsor Collaborator
University of Reading

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline endothelial dependent microvascular function as laser Doppler imaging (LDI) with iontophoresis Measurements will be taken by LDI with iontophoresis of endothelium-dependent (acetylcholine (ACh)) At baseline (t= 0.5 hours) and t= 3 hours
Primary Change from baseline endothelial independent microvascular function as laser Doppler imaging (LDI) with iontophoresis Measurements will be taken by LDI of endothelium-independent (sodium nitroprusside (SNP)) At baseline (t= 0.5 hours) and t= 3 hours
Primary Change from baseline cognitive function. Domain: Episodic memory -Rey Auditory Verbal Learning Test (RAVLT) task
Cognitive domains will be assessed by using the Gorilla online research tools.
At baseline (t= 0 hours) and t=2.5 hours
Primary Change from baseline cognitive function. Domain: Executive function 1 -Digit Span Task At baseline (t= 0 hours) and t=2.5 hours
Primary Change from baseline cognitive function. Domain: Executive function 2 -Stroop Task At baseline (t= 0 hours) and t=2.5 hours
Secondary Change in blood pressure Systolic and Diastolic Blood pressure measurement by automated device [Time Frame: At baseline (t= 0 hours) and 15 minute intervals until t= 2.5 hours.]
See also
  Status Clinical Trial Phase
Recruiting NCT03981341 - Impact of Estrogen + Estradiol Receptor Alpha Modulator Therapy on Oxidative Stress in Post-menopausal Women With and Without Sleep Apnea Phase 3
Completed NCT00060736 - The Effects of Estrogen Withdrawal on Mood Symptoms in Women
Recruiting NCT03036722 - Flaxseed Consumption and Bone Metabolism in Postmenopausal Women. N/A
Completed NCT00884143 - Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer N/A
Completed NCT01443455 - Adherence and Health Effects of Video Dance in Postmenopausal Women N/A
Completed NCT00660244 - Breast Cancer Tumor Care Observational Programme N/A
Recruiting NCT06166264 - Effects of Progressive Resistance Training Vasomotor Symptoms in Post Menopausal Women N/A